Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Real World Population- Based Data from Nationwide Registry Support the Existence of Accelerated Phase in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients Even in Tyrosine Kinase Inhibitors (TKIs) Era

Blood (2023) 142 (Supplement 1): 3166.

https://doi.org/10.1182/blood-2023-174455

Published: 2023

Journal Articles

Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses

Blood (2019) 134 (Supplement_1): 918.

https://doi.org/10.1182/blood-2019-127411

Published: 2019

Journal Articles

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Blood (2019) 133 (11): 1205–1216.

https://doi.org/10.1182/blood-2018-09-873083

Published: 2019

Includes: Supplemental data

Journal Articles

miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels

Blood (2018) 132 (22): 2389–2400.

https://doi.org/10.1182/blood-2018-06-855502

Published: 2018

Includes: Supplemental data

Journal Articles

Two Novel Mutations in Ribosomal Proteins in the Czech National Diamond-Blackfan Anemia Registry

Zuzana Maceckova, MSc, Pavla Koralkova, MSc, Jana Volejnikova, MD PhD, Petr Vojta, MSc, Alexandra Jungova, MD, Zuzana Saxova, MSc, Renata Mojzikova, MSc, PhD, Marie Jarosova, MSc PhD, Ivana Hadacova, MD, Marian Hajduch, MD PhD, Monika Horvathova, MSc, PhD, Dagmar Pospisilova, MD PhD

Blood (2016) 128 (22): 3903.

https://doi.org/10.1182/blood.V128.22.3903.3903

Published: 2016

Journal Articles

Backtracking Of The Genetic Events Preceding Acute Leukemia Diagnosis

Olga Zimmermannova, Marketa Zaliova, Ester Mejstrikova, Eva Fronkova, Marie Jarosova, Zuzana Zemanova, Libuse Lizcova, Halima A Al-Shehhi, Anthony V. Moorman, Ajay J Vora, Claus Meyer, Rolf Marschalek, Jan Stary, Jan Trka, Ondrej Hrusak, Jan Zuna

Blood (2013) 122 (21): 2562.

https://doi.org/10.1182/blood.V122.21.2562.2562

Published: 2013

Journal Articles

Programmed Death-1 Ligand Is Uniformly Expressed On Primary Mediastinal Diffuse Large B-Cell Lymphoma Cells with No Influence On Patient Survival.

Vit Prochazka, M.D., Ph.D., Tomas Papajik, Dr., Ph.D., Patrik Flodr, Dr., Pavla Latalova, Dr., Zuzana Prouzova, Dr., Radka Nedomova, Mgr., Marie Jarosova, Prof., Vladimir Divoky, Ph.D., ass. prof., Karel Indrak, MD, Prof.

Blood (2012) 120 (21): 2671.

https://doi.org/10.1182/blood.V120.21.2671.2671

Published: 2012

Journal Articles

Identification of Novel Molecular Markers for the Follow-up of Minimal Residual Disease in Hematooncological Disorders

David Warren Hardekopf, Tereza Jancuskova, Marie Jarosova, Lucie Krutilkova, Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, Jan Vydra, Tomas Kozak, MD, PhD, Michal Karas, Vladimir Koza, MD, Alzbeta Zavrelova, MD, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova

Blood (2011) 118 (21): 4905.

https://doi.org/10.1182/blood.V118.21.4905.4905

Published: 2011

Journal Articles

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.

Blood (2010) 116 (21): 1239.

https://doi.org/10.1182/blood.V116.21.1239.1239

Published: 2010

Journal Articles

Composition of Cellular Subsets by Flow Cytometry Identifies Differences Between MDS Subtypes and Aplastic Anemia but No Differences Are Identified Between Cases with and without Monosomy 7.

Blood (2009) 114 (22): 3802.

https://doi.org/10.1182/blood.V114.22.3802.3802

Published: 2009

Journal Articles

Imatinib Plasma Levels Correlate with Molecular Response in CML Patients

Sarka Rozmanova, Ms., David Friedecky, Ph.D., Adriana Polynkova, BC, Edgar Faber, MD, Peter Rohon, MD, Tomas Adam, Ph.D., Marie Jarosova, Karel Indrak, MD

Blood (2008) 112 (11): 4268.

https://doi.org/10.1182/blood.V112.11.4268.4268

Published: 2008

Journal Articles

Bcr-Abl-Independent Activation of Src Kinases Associated with Development of Dasatinib Resistance in a CML Patient.

Jitka Veselovska, MSc, Renata Solna, PhD, Marie Jarosova, PhD, Edgar Faber, MD, PhD, Helena Urbankova, MSc, Milena Holzerova, MSc, Jana Balcarkova, MSc, Karel Indrak, MD, PhD, Vladimir Divoky, PhD

Blood (2008) 112 (11): 1624.

https://doi.org/10.1182/blood.V112.11.1624.1624

Published: 2008

Journal Articles

Clinical Relevance of Complex Chromosomal Aberrations in Bone Marrow Cells of 107 Children with ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia (ALL).

Zuzana Zemanova, Kyra Michalova, Libuse Babicka, Lenka Pavlistova, Marie Jarosova, Milena Holzerova, Alexandra Oltova, Martina Hruba, Katerina Muzikova, Jan Zuna, Jan Trka, Vladimir Mihal, Jiri Sterba, Renata Formankova, Petr Sedlacek, Alena Vrzalova, Jan Stary

Blood (2006) 108 (11): 2278.

https://doi.org/10.1182/blood.V108.11.2278.2278

Published: 2006

Journal Articles

Balanced Rearrangements of Chromosome 6 in Acute Leukaemia: Clustered Breakpoints in 6q22-q23 and Possible Involvement of c-MYB / AHI1 in a New Recurrent Translocation, t(6;7)(q23;q31).

Paul B. Sinclair, PhD, Christine J. Harrison, PhD, Marie Jarosova, PhD, Letizia Foroni, MD, PhD

Blood (2004) 104 (11): 2893.

https://doi.org/10.1182/blood.V104.11.2893.2893

Published: 2004

Journal Articles

Intermittent Dosage of Imatinib - a Feasible Strategy for Patients with Significant Hematologic Toxicity during Standard Therapy.

Edgar Faber, Marie Jarosova, Jitka Nausova, Marie Holzerova, Svatopluk Skranc, Vladimir Divoky, Karel Indrak

Blood (2004) 104 (11): 4657.

https://doi.org/10.1182/blood.V104.11.4657.4657

Published: 2004

NARROW

Real World Population- Based Data from Nationwide Registry Support the Existence of Accelerated Phase in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients Even in Tyrosine Kinase Inhibitors (TKIs) Era

Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels

Two Novel Mutations in Ribosomal Proteins in the Czech National Diamond-Blackfan Anemia Registry

Backtracking Of The Genetic Events Preceding Acute Leukemia Diagnosis

Programmed Death-1 Ligand Is Uniformly Expressed On Primary Mediastinal Diffuse Large B-Cell Lymphoma Cells with No Influence On Patient Survival.

Identification of Novel Molecular Markers for the Follow-up of Minimal Residual Disease in Hematooncological Disorders

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.

Composition of Cellular Subsets by Flow Cytometry Identifies Differences Between MDS Subtypes and Aplastic Anemia but No Differences Are Identified Between Cases with and without Monosomy 7.

Imatinib Plasma Levels Correlate with Molecular Response in CML Patients

Bcr-Abl-Independent Activation of Src Kinases Associated with Development of Dasatinib Resistance in a CML Patient.

Clinical Relevance of Complex Chromosomal Aberrations in Bone Marrow Cells of 107 Children with ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia (ALL).

Balanced Rearrangements of Chromosome 6 in Acute Leukaemia: Clustered Breakpoints in 6q22-q23 and Possible Involvement of c-MYB / AHI1 in a New Recurrent Translocation, t(6;7)(q23;q31).

Intermittent Dosage of Imatinib - a Feasible Strategy for Patients with Significant Hematologic Toxicity during Standard Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only